blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4334331

EP4334331 - COMBINATION OF PRAME SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  09.02.2024
Database last updated on 19.10.2024
FormerThe international publication has been made
Status updated on  11.11.2022
Formerunknown
Status updated on  14.06.2022
Most recent event   Tooltip12.07.2024Change: Validation statespublished on 14.08.2024  [2024/33]
12.07.2024Change - extension statespublished on 14.08.2024  [2024/33]
Applicant(s)For all designated states
Medigene Immunotherapies GmbH
Lochhamer Straße 11
82152 Planegg-Martinsried / DE
[2024/11]
Inventor(s)01 / SAILER, Nadja
80538 München / DE
02 / SALVERMOSER, Melanie
81379 München / DE
03 / SOMMERMEYER, Daniel
80638 München / DE
04 / WILDE, Susanne
82110 Germering / DE
05 / FETZER, Ina
80469 München / DE
06 / BÜRDEK, Maja
81669 München / DE
 [2024/11]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[2024/11]
Application number, filing date22727928.806.05.2022
[2024/11]
WO2022EP62338
Priority number, dateEP2021017272207.05.2021         Original published format: EP 21172722
[2024/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022234116
Date:10.11.2022
Language:EN
[2022/45]
Type: A1 Application with search report 
No.:EP4334331
Date:13.03.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 10.11.2022 takes the place of the publication of the European patent application.
[2024/11]
Search report(s)International search report - published on:EP10.11.2022
ClassificationIPC:C07K7/00, C07K14/705, A61K39/395, A61K35/17, A61K38/00, A61P35/00, C07K14/725
[2024/11]
CPC:
C07K14/7051 (EP,KR,US); A61K35/17 (US); A61K2239/38 (EP,US);
A61K39/395 (EP); A61K39/4611 (EP,KR,US); A61K39/4631 (KR);
A61K39/4632 (EP,US); A61K39/4636 (EP,US); A61K39/464489 (EP,US);
A61P35/00 (EP,KR,US); C07K14/70503 (EP); C07K14/70521 (KR,US);
C07K14/70578 (KR,US); C12N15/86 (US); C12N5/0636 (EP,KR,US);
A61K2039/5156 (KR); A61K2039/5158 (KR); C07K2319/00 (EP);
C07K2319/02 (EP,KR,US); C07K2319/03 (EP,KR,US); C07K2319/33 (EP);
C12N2510/00 (EP); C12N2740/10043 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/11]
TitleGerman:KOMBINATION AUS PRAME-SPEZIFISCHEN T-ZELL-REZEPTOREN UND CHIMÄREN COSTIMULATORISCHEN REZEPTOREN[2024/11]
English:COMBINATION OF PRAME SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS[2024/11]
French:COMBINAISON DE RÉCEPTEURS DE LYMPHOCYTES T SPÉCIFIQUES DE PRAME ET DE RÉCEPTEURS CO-STIMULATEURS CHIMÉRIQUES[2024/11]
Entry into regional phase30.11.2023National basic fee paid 
30.11.2023Designation fee(s) paid 
30.11.2023Examination fee paid 
Examination procedure30.11.2023Examination requested  [2024/11]
30.11.2023Date on which the examining division has become responsible
18.06.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.05.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2016142783  (LEIDEN UNIV MEDICAL CENTER [NL]);
 [A]WO2017216324  (MEDIGENE IMMUNOTHERAPIES GMBH [DE]);
 [A]WO2018234319  (IMMUNOCORE LTD [GB]);
 [A]WO2019133853  (GRITSTONE ONCOLOGY INC [US]);
 [A]US2019247432  (ZHAO YANGBING [US], et al);
 [A]US2019330306  (NOONAN KIMBERLY A [US], et al);
 [XP]WO2021099360  (MEDIGENE IMMUNOTHERAPIES GMBH [DE]);
by applicantUS4703004
 US4851341
 EP2173869
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.